RxDoctor Payments Data

Daniel Moyse, MD

Pain Medicine · Des Moines, IANPI 1508155524

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Medtronic at 31.9% of the total. Reporting peaked in 2019 at $10,449 and has fallen 78.8% since, to $2,213 in 2025. Among pain medicine clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$39,975in general payments, 2019–2025

Across 401 payments — averaging $99.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$13K
  • Boston Scientific$12K
  • Nevro Corp.$5K
  • Abbott$3K
  • Saluda Medical Americas, Inc.$2K
  • MML US, Inc.$915
  • plus $4K from 16 others
$46,510in research payments, 2019–2025

Across 8 payments — averaging $5813.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$47K

What the payments were for

  • Speaking & faculty fees$11,06328%
  • Travel & lodging$7,11418%
  • Food & beverage$20,79352%
  • Education$1,0063%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$39,975 in reported general payments places this provider in the 90th percentile of 31 pain medicine providers in Iowa.

See all pain medicine providers in Iowa

Medicare billing

Part B allowed, 2024
$189,568
Medicare patients
394
Services billed
2,740

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin104$2,845
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen144$2,177
Gabapentin204$1,619
Tizanidine Hcl97$969
Baclofen64$892
Lidocaine13$857
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen37$824
Duloxetine Hcl48$662
Fentanyl12$535
Indomethacin12$453
Methocarbamol26$441
Oxycodone Hcl41$388
Cyclobenzaprine Hcl24$279
Nortriptyline Hcl19$199
Diclofenac Sodium13$97

Paid to pharmacies, not to this prescriber.

Other pain medicine in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →